QTc-interval prolongation and increased risk of sudden cardiac death associated with hydroxychloroquine
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
QTc-interval prolongation and increased risk of sudden cardiac death associated with hydroxychloroquine
Authors
Keywords
-
Journal
European Journal of Preventive Cardiology
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2021-01-01
DOI
10.1093/eurjpc/zwaa118
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Impact of rheumatoid arthritis on major cardiovascular events in patients with and without coronary artery disease
- (2020) Brian Bridal Løgstrup et al. ANNALS OF THE RHEUMATIC DISEASES
- Cardiovascular Toxicities Associated with Hydroxychloroquine and Azithromycin: An Analysis of the World Health Organization Pharmacovigilance Database
- (2020) Lee S. Nguyen et al. CIRCULATION
- Objectives, design and main findings until 2020 from the Rotterdam Study
- (2020) M. Arfan Ikram et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
- (2020) Joshua Geleris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Covid-19: WHO halts hydroxychloroquine trial to review links with increased mortality risk
- (2020) Elisabeth Mahase BMJ-British Medical Journal
- Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2
- (2020) Markus Hoffmann et al. NATURE
- Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates
- (2020) Pauline Maisonnasse et al. NATURE
- Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621.
- (2020) Mandeep R. Mehra et al. NEW ENGLAND JOURNAL OF MEDICINE
- Is hydroxychloroquine beneficial for COVID-19 patients?
- (2020) Xing Li et al. Cell Death & Disease
- Hydroxychloroquine: A Physiologically-Based Pharmacokinetic Model in the Context of Cancer-Related Autophagy Modulation
- (2018) Keagan P. Collins et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Hydroxychloroquine-induced restrictive cardiomyopathy: a case report
- (2018) Muhammad U Dogar et al. POSTGRADUATE MEDICAL JOURNAL
- CredibleMeds.org: What does it offer?
- (2018) Raymond L. Woosley et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Hydroxychloroquine-Induced Cardiomyopathy in Systemic Lupus Erythematosus
- (2016) Konstantinos Tselios et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Declining incidence of sudden cardiac death from 1990–2010 in a general middle-aged and elderly population: The Rotterdam Study
- (2015) Maartje N. Niemeijer et al. HEART RHYTHM
- Hydroxychloroquine-Induced Cardiomyopathy: Case Report, Pathophysiology, Diagnosis, and Treatment
- (2014) Haran Yogasundaram et al. CANADIAN JOURNAL OF CARDIOLOGY
- Development and Validation of a Risk Score to Predict QT Interval Prolongation in Hospitalized Patients
- (2013) James E. Tisdale et al.
- Chloroquine: Modes of action of an undervalued drug
- (2013) Rodolfo Thomé et al. IMMUNOLOGY LETTERS
- Trends in stroke incidence rates and stroke risk factors in Rotterdam, the Netherlands from 1990 to 2008
- (2012) Renske G. Wieberdink et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- The role of antimalarial agents in the treatment of SLE and lupus nephritis
- (2011) Senq-J Lee et al. Nature Reviews Nephrology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started